Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion
Keywords:
Human papillomavirus, Viral load, Cervical intraepithelial neoplasiaAbstract
CONTEXT: Human papillomavirus (HPV) viral load may have an important role in predicting high-grade cervical intraepithelial neoplasia (CIN) in women with cervical smears showing atypical squamous cells or LSIL. OBJECTIVE: To determine whether the assessment of the viral load of high-risk HPV DNA is useful in predicting the detection of high-grade cervical intraepithelial neoplasia (CIN2 and 3) in women referred because of cervical smears showing only atypical squamous cells or LSIL. TYPE OF STUDY: Cross-sectional SETTING: Colposcopy Clinic in a University hospital. METHODS: A series of 119 women referred because of atypical squamous cells or LSIL between August 2000 and April 2001 were included. All women were subjected to a new cervical smear, HPV testing for the high-risk types using hybrid capture II (HCII), viral load measurement in relative light units (RLU) and colposcopy, with cervical biopsies (n = 97). Cervical lesions were graded using the CIN classification. RESULTS: Cervical biopsies revealed CIN2 or CIN3 in 11% of the cases, equally among women referred because of atypical squamous cells or LSIL. The HCII test was positive in 16% of women with atypical squamous cells and 52% of those with LSIL (OR = 5.8; 95% CI 1.4 to 26.7). There was strong correlation between CIN2 or CIN3 and positivity for HPV DNA when this group was compared with women with only CIN1 or normal cervix (OR = 7.8; 95% CI 1.5 to 53.4). In ROC analysis for HCII in diagnosing CIN2 and CIN3, the area under the ROC curve was 0.784, and the viral load cutoff point of 10.0 RLU/cutoff presented 77% sensitivity and 73% specificity. Second cytology showing at least atypical squamous cells did not accurately detect CIN2 or CIN3 (OR = 6.4; 95% CI 1.0 to 50.9). The sensitivities of the second cervical smear and HCII were similar, although the specificity of HCII was significantly higher than the second cervical smear. CONCLUSIONS: The viral load of high-risk HPV types was significantly associated with the diagnosis of CIN2 or CIN3 in women referred because of atypical squamous cells and LSIL abnormalities in their cervical smear.
Downloads
References
Solomon D, Schiffman M, Tarone R. Comparison of three man- agement strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93(4):293-9.
Lee NW, Kim D, Park JT, Kim A. Is the human papillomavirus test combination with the Papanicolaou test useful for manage- ment of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions? Arch Pathol Lab Med 2001;125(11):1453-7.
Herbst AL, Pickett KE, Follen M, Noller KL. The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol 2001;98(5 Pt 1):849-51.
Paraskevaidis E, Malamou-Mitsi V, Koliopoulos G, et al. Ex- panded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing. Gynecol Oncol 2001;82(2):355-9.
Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Signifi- cance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94(2):102-7.
Hughes SA, Sun D, Gibson C, et al. Managing atypical squa- mous cells of undetermined significance (ASCUS): human papillomavirus testing, ASCUS subtyping, or follow-up cytol- ogy? Am J Obstet Gynecol 2002;186(3):396-403.
Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Can- cer Inst 2000;92(5)397-402.
Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001Consensus Guidelines for the management of women with cer- vical cytological abnormalities. JAMA 2002;287(16):2120-9.
Syrjänen S, Shabalova IP, Petrovichev N, et al. Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former Soviet Union. J Lower Genital Tract Dis 2002;6(2):97-110.
Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287(16):2114-9.
Gamzu R, Almog B, Levin I, et al. Clinical and economic im- plication of adding HPV tests to the routine cytology follow- up and management of patients with histologically defined cer- vical intraepithelial neoplasia grade 1. Gynecol Oncol 2002;86(2):129-33.
Stafl A, Wilbanks GD. An international terminology of colpos- copy: report of the Nomenclature Committee of the Interna- tional Federation of Cervical Pathology and Colposcopy. Obstet Gynecol 1991;77(2):313-4.
Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkins EJ. Histological typing of female genital tract tumors. World Health Organization - International histological classification of tumors. 2nd ed. Berlin: Springer-Verlag; 1994.
Begg CB, Greenes RA. Assessment of diagnostic tests when dis- ease verification is subject to selection bias. Biometrics 1983;39(1):207-15.
Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high- risk HPV, routine cytology or colposcopy. Int J Cancer 2000;89(6):529-34.
Zerbini M, Venturoli S, Cricca M, et al. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol 2001;54(5):377-80.
Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355(9222):2189-93.
Abba MC, Mourón SA, Gómez MA, Dulout FN, Golijow CD. Association of human papillomavirus viral load with HPV16 and high-grade intraepithelial lesion. Int J Gynecol Cancer 2003;13(2):154-8.
Gravitt PE, Burk RD, Lorincz A, et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 2003;12(6):477-84.
Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA test- ing in cervical cancer screening: result from women in a high- risk province of Costa Rica. JAMA 2000;283(1):87-93.
Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial le- sions of uterine cervix. Gynecol Oncol 2001;83(1):95-9.
Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002;76(1):41-7.
Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360(9328):228-9.
Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classi- fication of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348(6):518-27.
Schelecht NF, Trevisan A, Duarte-Franco E, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003;103(4):519-24.
